Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study

Baili Chen,Jie Zhong,Xiuling Li,Feng Pan,Yijuan Ding,Yan Zhang,Hong Chen,Fei Liu,Zhenyu Zhang, Ling Zhang, Rafal Drozda, Oleksandr Oliinyk,Aik Han Goh, Xiang Chen, Xiang Sun,David T. Rubin,William J. Sandborn,Minhu Chen

Gastroenterology（2022）

Cited 16|Views22
No score
Abstract
Oral ivarmacitinib was found to be a safe and effective therapy for adult patients with moderate-to-severe, active ulcerative colitis, and holds promise as a new treatment option for this condition.
More
Translated text
Key words
Ulcerative Colitis,Ivarmacitinib (SHR0302),JAK1 Inhibitor,Safety,Clinical Remission
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined